BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 2 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 2 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 3 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 3 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 3 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 3 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 3 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 3 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 5 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 6 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 2 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 2 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 3 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 3 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 3 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 3 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 3 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 3 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 5 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 6 hours ago
ADVERTISEMENT
Analysis

Centerspace reports wider Q4 loss, provides 2026 outlook amid ongoing strategic review

February 18, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

Centerspace (NYSE: CSR) on Tuesday reported a wider net loss for the fourth quarter of 2025, even as its core operational metrics showed growth and the company continued its previously announced review of strategic alternatives.

Operational Performance

Strategic Review and Portfolio Shifts

The company’s Board of Trustees is continuing a proactive review of strategic alternatives to maximize shareholder value, a process first announced in November 2025. Centerspace stated the review remains ongoing with no definitive timetable for completion.
Throughout the full year 2025, Centerspace aggressively reshaped its portfolio:
Acquisitions: The company purchased two apartment communities Sugarmont in Salt Lake City and Railway Flats in Colorado for a combined $281.2 million.
Dispositions: It sold 12 non-core apartment communities in Minnesota and one corporate office building for approximately $215.5 million.
Share Repurchases: Centerspace repurchased 62,973 shares at an average price of $54.86.

2026 Outlook

Looking ahead, Centerspace issued a 2026 financial outlook, forecasting Core FFO in the range of $4.81 to $5.05 per diluted share. The company expects a full-year net loss per share between $0.49 and $0.19. For its same-store portfolio in 2026, the company projects NOI growth between (0.50)% and 2.00%, driven by expected revenue growth of 0% to 1.75%.
The Board also declared a quarterly distribution of $0.77 per share, payable on April 14, 2026, to shareholders of record as of March 30.
At year-end, Centerspace maintained total liquidity of $267.9 million, including $255.1 million available on its lines of credit.

ADVERTISEMENT
Tags: #REIT